Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial

Sonja Zweegman; Fredrik H. Schjesvold; Bronno van der Holt; Mark-David Levin; Claudia A. M. Stege; Anders Waage; Maria B. L. Leijs; Saskia K. Klein; Damian L. Szatkowski; Per Axelsson; Trung Hieu Do; Dorota Knut-Bojanovska; Ellen van der Spek; Asta Svirskaite; Pino Poddighe; Marian Stevens-Kroef; Markus Hansson; Niels W. C. J. van de Donk; Einar Haukas; Pieter Sonneveld; Niels Abildgaard

doi:10.1182/blood-2018-99-111650

Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial

Sonja Zweegman, Fredrik H. Schjesvold, Bronno van der Holt, Mark-David Levin, Claudia A. M. Stege, Anders Waage, Maria B. L. Leijs, Saskia K. Klein, Damian L. Szatkowski, Per Axelsson, Trung Hieu Do, Dorota Knut-Bojanovska, Ellen van der Spek, Asta Svirskaite, Pino Poddighe, Marian Stevens-Kroef, Markus Hansson, Niels W. C. J. van de Donk, Einar Haukas, Pieter SonneveldNiels Abildgaard

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Blood
Vol/bind	132
Udgave nummer	Suppl. 1
Sider (fra-til)	800-800
Antal sider	1
ISSN	0006-4971
DOI	https://doi.org/10.1182/blood-2018-99-111650
Status	Udgivet - nov. 2018
Begivenhed	60th ASH Annual Meeting & Exposition - San Diego, USA Varighed: 1 dec. 2018 → 4 dec. 2018 Konferencens nummer: 60

Konference

Konference	60th ASH Annual Meeting & Exposition
Nummer	60
Land/Område	USA
By	San Diego
Periode	01/12/2018 → 04/12/2018

Adgang til dokumentet

10.1182/blood-2018-99-111650

http://www.bloodjournal.org.auh.aub.aau.dk/content/132/Suppl_1/800

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Zweegman, S., Schjesvold, F. H., van der Holt, B., Levin, M-D., Stege, C. A. M., Waage, A., Leijs, M. B. L., Klein, S. K., Szatkowski, D. L., Axelsson, P., Do, T. H., Knut-Bojanovska, D., van der Spek, E., Svirskaite, A., Poddighe, P., Stevens-Kroef, M., Hansson, M., van de Donk, N. W. C. J., Haukas, E., ... Abildgaard, N. (2018). Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial. Blood, 132(Suppl. 1), 800-800. https://doi.org/10.1182/blood-2018-99-111650

Zweegman, Sonja ; Schjesvold, Fredrik H. ; van der Holt, Bronno et al. / Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial. I: Blood. 2018 ; Bind 132, Nr. Suppl. 1. s. 800-800.

@article{4f35c2727d944ac3bbf67356fb7c3e6e,

title = "Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial",

author = "Sonja Zweegman and Schjesvold, {Fredrik H.} and {van der Holt}, Bronno and Mark-David Levin and Stege, {Claudia A. M.} and Anders Waage and Leijs, {Maria B. L.} and Klein, {Saskia K.} and Szatkowski, {Damian L.} and Per Axelsson and Do, {Trung Hieu} and Dorota Knut-Bojanovska and {van der Spek}, Ellen and Asta Svirskaite and Pino Poddighe and Marian Stevens-Kroef and Markus Hansson and {van de Donk}, {Niels W. C. J.} and Einar Haukas and Pieter Sonneveld and Niels Abildgaard",

year = "2018",

month = nov,

doi = "10.1182/blood-2018-99-111650",

language = "English",

volume = "132",

pages = "800--800",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

number = "Suppl. 1",

note = "60th ASH Annual Meeting & Exposition ; Conference date: 01-12-2018 Through 04-12-2018",

}

Zweegman, S, Schjesvold, FH, van der Holt, B, Levin, M-D, Stege, CAM, Waage, A, Leijs, MBL, Klein, SK, Szatkowski, DL, Axelsson, P, Do, TH, Knut-Bojanovska, D, van der Spek, E, Svirskaite, A, Poddighe, P, Stevens-Kroef, M, Hansson, M, van de Donk, NWCJ, Haukas, E, Sonneveld, P & Abildgaard, N 2018, 'Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial', Blood, bind 132, nr. Suppl. 1, s. 800-800. https://doi.org/10.1182/blood-2018-99-111650

Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial. / Zweegman, Sonja; Schjesvold, Fredrik H.; van der Holt, Bronno et al.
I: Blood, Bind 132, Nr. Suppl. 1, 11.2018, s. 800-800.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial

AU - Zweegman, Sonja

AU - Schjesvold, Fredrik H.

AU - van der Holt, Bronno

AU - Levin, Mark-David

AU - Stege, Claudia A. M.

AU - Waage, Anders

AU - Leijs, Maria B. L.

AU - Klein, Saskia K.

AU - Szatkowski, Damian L.

AU - Axelsson, Per

AU - Do, Trung Hieu

AU - Knut-Bojanovska, Dorota

AU - van der Spek, Ellen

AU - Svirskaite, Asta

AU - Poddighe, Pino

AU - Stevens-Kroef, Marian

AU - Hansson, Markus

AU - van de Donk, Niels W. C. J.

AU - Haukas, Einar

AU - Sonneveld, Pieter

AU - Abildgaard, Niels

N1 - Conference code: 60

PY - 2018/11

Y1 - 2018/11

U2 - 10.1182/blood-2018-99-111650

DO - 10.1182/blood-2018-99-111650

M3 - Conference abstract in journal

SN - 0006-4971

VL - 132

SP - 800

EP - 800

JO - Blood

JF - Blood

IS - Suppl. 1

T2 - 60th ASH Annual Meeting & Exposition

Y2 - 1 December 2018 through 4 December 2018

ER -

Zweegman S, Schjesvold FH, van der Holt B, Levin M-D, Stege CAM, Waage A et al. Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial. Blood. 2018 nov.;132(Suppl. 1):800-800. doi: 10.1182/blood-2018-99-111650